Phreesia Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 78/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 31.88.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Phreesia Inc's Score
Industry at a Glance
Industry Ranking
78 / 482
Overall Ranking
137 / 4563
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
18
analysts
Buy
Current Rating
31.882
Target Price
+58.46%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Phreesia Inc Highlights
StrengthsRisks
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 49.45% year-on-year.
Undervalued
The company’s latest PE is -188.44, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 64.80M shares, decreasing 7.88% quarter-over-quarter.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Ticker SymbolPHR
CompanyPhreesia Inc
CEOIndig (Chaim Edwards)
Websitehttps://www.phreesia.com
FAQs
What is the current price of Phreesia Inc (PHR)?
The current price of Phreesia Inc (PHR) is 17.010.
What is the symbol of Phreesia Inc?
The ticker symbol of Phreesia Inc is PHR.
What is the 52-week high of Phreesia Inc?
The 52-week high of Phreesia Inc is 32.760.
What is the 52-week low of Phreesia Inc?
The 52-week low of Phreesia Inc is 15.410.
What is the market capitalization of Phreesia Inc?
The market capitalization of Phreesia Inc is 1.02B.
What is the net income of Phreesia Inc?
The net income of Phreesia Inc is -58.53M.
Is Phreesia Inc (PHR) currently rated as Buy, Hold, or Sell?
According to analysts, Phreesia Inc (PHR) has an overall rating of Buy, with a price target of 31.882.
What is the Earnings Per Share (EPS TTM) of Phreesia Inc (PHR)?
The Earnings Per Share (EPS TTM) of Phreesia Inc (PHR) is -0.090.